Taro Pharmaceuticals U.s.a., Inc.
Overview
Taro Pharmaceuticals U.s.a., Inc. is a pharmaceutical company headquartered in Hawthorne, United States, with 201-500 employees.
FDA compliance signals
39 FDA enforcement records linked to this company.
- recall — Class III2024-08-21
Failed Impurities/Degradation Specifications: Out-of-specification results obtained for related impurities and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.
- recall — Class III2022-04-06
Failed Content Uniformity Specifications: Out-of-specification result for the Betamethasone Dipropionate assay of a stability sample
- recall — Class I2022-01-19
Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria
- recall — Class II2021-02-10
CGMP deviations.
- recall — Class II2020-12-23
Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.
- recall — Class II2020-12-23
Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.
- recall — Class II2020-12-23
Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.
- recall — Class II2020-12-23
Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.
- recall — Class II2020-12-23
Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.
- recall — Class II2020-12-23
Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.
- recall — Class II2020-12-23
Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.
- recall — Class II2020-12-23
Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.
- recall — Class II2020-12-23
Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.
- recall — Class II2020-12-23
Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.
- recall — Class III2020-08-19
Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.
Is this Taro Pharmaceuticals U.s.a., Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.